|
1
|
Frey N, Katus HA, Olson EN and Hill JA:
Hypertrophy of the heart: A new therapeutic target? Circulation.
109:1580–1589. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carreño JE, Apablaza F, Ocaranza MP and
Jalil JE: Cardiac hypertrophy: Molecular and cellular events. Rev
Esp Cardiol. 59:473–486. 2006.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alessi DR, Sakamoto K and Bayascas JR:
LKB1-dependent signaling pathways. Annu Rev Biochem. 75:137–163.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shaw RJ, Kosmatka M, Bardeesy N, Hurley
RL, Witters LA, DePinho RA and Cantley LC: The tumor suppressor
LKB1 kinase directly activates AMP-activated kinase and regulates
apoptosis in response to energy stress. Proc Natl Acad Sci USA.
101:3329–3335. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hawley SA, Boudeau J, Reid JL, Mustard KJ,
Udd L, Mäkelä TP, Alessi DR and Hardie DG: Complexes between the
LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are
upstream kinases in the AMP-activated protein kinase cascade. J
Biol. 2:282003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baas AF, Boudeau J, Sapkota GP, Smit L,
Medema R, Morrice NA, Alessi DR and Clevers HC: Activation of the
tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD.
EMBO J. 22:3062–3072. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stapleton D, Mitchelhill KI, Gao G, Widmer
J, Michell BJ, Teh T, House CM, Fernandez CS, Cox T, Witters LA and
Kemp BE: Mammalian AMP-activated protein kinase subfamily. J Biol
Chem. 271:611–614. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alexander A and Walker CL: The role of
LKB1 and AMPK in cellular responses to stress and damage. FEBS
Lett. 585:952–957. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zaha VG and Young LH: AMP-activated
protein kinase regulation and biological actions in the heart. Circ
Res. 111:800–814. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Steppan CM, Bailey ST, Bhat S, Brown EJ,
Banerjee RR, Wright CM, Patel HR, Ahima RS and Lazar MA: The
hormone resistin links obesity to diabetes. Nature. 409:307–312.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim M, Oh JK, Sakata S, Liang I, Park W,
Hajjar RJ and Lebeche D: Role of resistin in cardiac contractility
and hypertrophy. J Mol Cell Cardiol. 45:270–280. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Graveleau C, Zaha VG, Mohajer A, Banerjee
RR, Dudley-Rucker N, Steppan CM, Rajala MW, Scherer PE, Ahima RS,
Lazar MA and Abel ED: Mouse and human resistins impair glucose
transport in primary mouse cardiomyocytes and oligomerization is
required for this biological action. J Biol Chem. 280:31679–31685.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kang S, Chemaly ER, Hajjar RJ and Lebeche
D: Resistin promotes cardiac hypertrophy via the AMP-activated
protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun
N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
J Biol Chem. 286:18465–18473. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun B, Huo R, Sheng Y, Li Y, Xie X, Chen
C, Liu HB, Li N, Li CB, Guo WT, et al: Bone morphogenetic protein-4
mediates cardiac hypertrophy, apoptosis and fibrosis in
experimentally pathological cardiac hypertrophy. Hypertension.
61:352–360. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Merten KE, Jiang Y and Kang YJ: Zinc
inhibits doxorubicin-activated calcineurin signal transduction
pathway in H9c2 embryonic rat cardiac cells. Exp Biol Med
(Maywood). 232:682–689. 2007.PubMed/NCBI
|
|
16
|
Shaw RJ, Lamia KA, Vasquez D, Koo SH,
Bardeesy N, Depinho RA, Montminy M and Cantley LC: The kinase LKB1
mediates glucose homeostasis in liver and therapeutic effects of
metformin. Science. 310:1642–1646. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou G, Myers R, Li Y, Chen Y, Shen X,
Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, et al: Role of
AMP-activated protein kinase in mechanism of metformin action. J
Clin Invest. 108:1167–1174. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Patel L, Buckels AC, Kinghorn IJ, Murdock
PR, Holbrook JD, Plumpton C, Macphee CH and Smith SA: Resistin is
expressed in human macrophages and directly regulated by PPAR gamma
activators. Biochem Biophys Res Commun. 300:472–476. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu SC, Shieh WY, Chen CY, Hsu SC and Chen
HL: Lipopolysaccharide increases resistin gene expression in vivo
and in vitro. FEBS Lett. 530:158–162. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kaser S, Kaser A, Sandhofer A, Ebenbichler
CF, Tilg H and Patsch JR: Resistin messenger-RNA expression is
increased by proinflammatory cytokines in vitro. Biochem Biophys
Res Commun. 309:286–290. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lehrke M, Reilly MP, Millington SC, Iqbal
N, Rader DJ and Lazar MA: An inflammatory cascade leading to
hyperresistinemia in humans. PLoS Med. 1:e452004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Banerjee RR, Rangwala SM, Shapiro JS, Rich
AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, et al:
Regulation of fasted blood glucose by resistin. Science.
303:1195–1198. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Muse ED, Obici S, Bhanot S, Monia BP,
McKay RA, Rajala MW, Scherer PE and Rossetti L: Role of resistin in
diet-induced hepatic insulin resistance. J Clin Invest.
114:232–239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rajala MW, Obici S, Scherer PE and
Rossetti L: Adipose-derived resistin and gut-derived resistin-like
molecule-beta selectively impair insulin action on glucose
production. J Clin Invest. 111:225–230. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chemaly ER, Hadri L, Zhang S, Kim M,
Kohlbrenner E, Sheng J, Liang L, Chen J, K-Raman P, Hajjar RJ and
Lebeche D: Long-term in vivo resistin overexpression induces
myocardial dysfunction and remodeling in rats. J Mol Cell Cardiol.
51:144–155. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sanchez-Cespedes M, Parrella P, Esteller
M, Nomoto S, Trink B, Engles JM, Westra WH, Herman JG and Sidransky
D: Inactivation of LKB1/STK11 is a common event in adenocarcinomas
of the lung. Cancer Res. 62:3659–3662. 2002.PubMed/NCBI
|
|
27
|
Guldberg P, Straten Thor P, Ahrenkiel V,
Seremet T, Kirkin AF and Zeuthen J: Somatic mutation of the
Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma.
Oncogene. 18:1777–1780. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
McCabe MT, Powell DR, Zhou W and Vertino
PM: Homozygous deletion of the STK11/LKB1 locus and the generation
of novel fusion transcripts in cervical cancer cells. Cancer Genet
Cytogenet. 197:130–141. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng B, Jeong JH, Asara JM, Yuan YY,
Granter SR, Chin L and Cantley LC: Oncogenic B-RAF negatively
regulates the tumor suppressor LKB1 to promote melanoma cell
proliferation. Mol Cell. 33:237–247. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Oakhill JS, Chen ZP, Scott JW, Steel R,
Castelli LA, Ling N, Macaulay SL and Kemp BE: β-Subunit
myristoylation is the gatekeeper for initiating metabolic stress
sensing by AMP-activated protein kinase (AMPK). Proc Natl Acad Sci
USA. 107:19237–19241. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dolinsky VW, Chan AY, Frayne Robillard I,
Light PE, Des Rosiers C and Dyck JR: Resveratrol prevents the
prohypertrophic effects of oxidative stress on LKB1. Circulation.
119:1643–1652. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Calamaras TD, Lee C, Lan F, Ido Y, Siwik
DA and Colucci WS: Post-translational modification of
serine/threonine kinase LKB1 via adduction of the reactive lipid
species 4-Hydroxy-trans-2-nonenal (HNE) at lysine residue 97
directly inhibits kinase activity. J Biol Chem. 287:42400–42406.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
El-Mir MY, Nogueira V, Fontaine E, Avéret
N, Rigoulet M and Leverve X: Dimethylbiguanide inhibits cell
respiration via an indirect effect targeted on the respiratory
chain complex I. J Biol Chem. 275:223–228. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Owen MR, Doran E and Halestrap AP:
Evidence that metformin exerts its anti-diabetic effects through
inhibition of complex 1 of the mitochondrial respiratory chain.
Biochem J. 348:607–614. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shackelford DB, Abt E, Gerken L, Vasquez
DS, Seki A, Leblanc M, Wei L, Fishbein MC, Czernin J, Mischel PS
and Shaw RJ: LKB1 inactivation dictates therapeutic response of
non-small cell lung cancer to the metabolism drug phenformin.
Cancer Cell. 23:143–158. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou W, Marcus AI and Vertino PM:
Dysregulation of mTOR activity through LKB1 inactivation. Chin J
Cancer. 32:427–433. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Calamaras TD, Lee C, Lan F, Ido Y, Siwik
DA and Colucci WS: The lipid peroxidation product
4-hydroxy-trans-2-nonenal causes protein synthesis in cardiac
myocytes via activated mTORC1-p70S6K-RPS6 signaling. Free Radic
Biol Med. 82:137–146. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kuwabara Y, Horie T, Baba O, Watanabe S,
Nishiga M, Usami S, Izuhara M, Nakao T, Nishino T, Otsu K, et al:
MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and
high-fat diet-induced cardiac hypertrophy in mice through
suppression of the LKB1/AMPK pathway. Circ Res. 116:279–288. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dolinsky VW, Chakrabarti S, Pereira TJ,
Oka T, Levasseur J, Beker D, Zordoky BN, Morton JS, Nagendran J,
Lopaschuk GD, et al: Resveratrol prevents hypertension and cardiac
hypertrophy in hypertensive rats and mice. Biochim Biophys Acta.
1832:1723–1733. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pillai VB, Sundaresan NR, Kim G, Gupta M,
Rajamohan SB, Pillai JB, Samant S, Ravindra PV, Isbatan A and Gupta
MP: Exogenous NAD blocks cardiac hypertrophic response via
activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol
Chem. 285:3133–3144. 2010. View Article : Google Scholar : PubMed/NCBI
|
